These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 37012662)

  • 1. PU.1 is a useful nuclear marker to distinguish between histiocytosis and histiocyte-rich tumours.
    Ungureanu IA; Cohen-Aubart F; Héritier S; Haroche J; Donadieu J; Emile JF
    Histopathology; 2023 Aug; 83(2):320-325. PubMed ID: 37012662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. OCT2 expression in histiocytoses.
    Ungureanu IA; Cohen-Aubart F; Héritier S; Fraitag S; Charlotte F; Lequain H; Hélias-Rodzewicz Z; Haroche J; Donadieu J; Emile JF
    Virchows Arch; 2023 Jul; 483(1):81-86. PubMed ID: 36754897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of neuroimaging features of histiocytic neoplasms with central nervous system involvement: a retrospective study of 121 adult patients.
    Fan X; Liu T; Zhang Z; Sun J; Niu N; Mao C; Wang F; Li J; Zhou D; Cao X; Jin Z; Feng F
    Eur Radiol; 2023 Nov; 33(11):8031-8042. PubMed ID: 37191919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disseminated histiocytoses biomarkers beyond BRAFV600E: frequent expression of PD-L1.
    Gatalica Z; Bilalovic N; Palazzo JP; Bender RP; Swensen J; Millis SZ; Vranic S; Von Hoff D; Arceci RJ
    Oncotarget; 2015 Aug; 6(23):19819-25. PubMed ID: 26110571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strong Coexpression of Transcription Factors PU.1 and Oct-2 in Rosai-Dorfman Disease.
    Kiruthiga KG; Younes S; Natkunam Y
    Am J Clin Pathol; 2022 Dec; 158(6):672-677. PubMed ID: 36239684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic Histiocytosis (Langerhans Cell Histiocytosis, Erdheim-Chester Disease, Destombes-Rosai-Dorfman Disease): from Oncogenic Mutations to Inflammatory Disorders.
    Papo M; Cohen-Aubart F; Trefond L; Bauvois A; Amoura Z; Emile JF; Haroche J
    Curr Oncol Rep; 2019 May; 21(7):62. PubMed ID: 31115724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MAP2K1-driven mixed Langerhans cell histiocytosis, Rosai-Dorfman-Destombes disease and Erdheim-Chester disease, clonally related to acute myeloid leukemia.
    Bonometti A; Ferrario G; Parafioriti A; Giardino D; Simonetti F; Ginori A; Passoni E; Berti E;
    J Cutan Pathol; 2021 May; 48(5):637-643. PubMed ID: 33188581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How I Diagnose Rosai-Dorfman Disease.
    Ravindran A; Rech KL
    Am J Clin Pathol; 2023 Jul; 160(1):1-10. PubMed ID: 37167084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinicopathologic analysis of extranodal Rosai-Dorfman disease of breast: a report of 12 cases].
    Chen YP; Jiang XN; Lu JP; Zhang H; Li XQ; Chen G
    Zhonghua Bing Li Xue Za Zhi; 2016 Aug; 45(8):556-60. PubMed ID: 27510782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histiocytic disorders of the gastrointestinal tract.
    Detlefsen S; Fagerberg CR; Ousager LB; Lindebjerg J; Marcussen N; Nathan T; Sørensen FB
    Hum Pathol; 2013 May; 44(5):683-96. PubMed ID: 23063502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Histiocytic diseases in childhood and adolescence].
    Vokuhl C; Oschlies I; Klapper W; Leuschner I
    Pathologe; 2015 Sep; 36(5):443-50. PubMed ID: 26292932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The changing landscape of pediatric histiocytoses: Birth, life, and transdifferentiation of pediatric histiocytes.
    Auerbach A; Aguilera NS
    Semin Diagn Pathol; 2023 Nov; 40(6):420-428. PubMed ID: 37258365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Erdheim-Chester disease and Rosai-Dorfman disease: Pathological, radiological and clinical features of adult non-Langerhans cell histiocytosis].
    Bösmüller H; Nann D; Horger M; Fend F
    Pathologe; 2015 Sep; 36(5):458-66. PubMed ID: 26305142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pulmonary histiocytosis: beyond Langerhans cell histiocytosis related to smoking.
    Gallego CT; Bueno J; Cruces E; Stelow EB; Mancheño N; Flors L
    Radiologia (Engl Ed); 2019; 61(3):215-224. PubMed ID: 30686482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The histiocytoses: clinical presentation and differential diagnosis.
    Gonzalez CL; Jaffe ES
    Oncology (Williston Park); 1990 Nov; 4(11):47-60; discussion 60, 62. PubMed ID: 2150325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CNS Erdheim-Chester Disease: A Challenge to Diagnose.
    Pan Z; Kleinschmidt-DeMasters BK
    J Neuropathol Exp Neurol; 2017 Dec; 76(12):986-996. PubMed ID: 29096034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurological Manifestations of Histiocytic Disorders.
    Banks SA; Sartori Valinotti JC; Go RS; Abeykoon JP; Goyal G; Young JR; Koster MJ; Vassallo R; Ryu JH; Davidge-Pitts CJ; Ravindran A; Bennani NN; Shah MV; Rech KL; Tobin WO;
    Curr Neurol Neurosci Rep; 2023 Jun; 23(6):277-286. PubMed ID: 37209319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Challenges in the Histopathologic Diagnosis of Histiocytic Neoplasms.
    Rech KL; He R
    J Natl Compr Canc Netw; 2021 Nov; 19(11):1305-1311. PubMed ID: 34781270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-Langerhans cell histiocytosis with isolated CNS involvement: an unusual variant of Erdheim-Chester disease.
    Conley A; Manjila S; Guan H; Guthikonda M; Kupsky WJ; Mittal S
    Neuropathology; 2010 Dec; 30(6):634-47. PubMed ID: 20337948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emperipolesis in the cerebrospinal fluid from a patient with Rosai-Dorfman disease.
    Kraeft SK; Honig M; Krishnamurthy S
    Diagn Cytopathol; 2008 Jan; 36(1):67-8. PubMed ID: 18064697
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.